OncoDxRx is a patient-centered, innovation-driven liquid biopsy company. We develop, validate and offer exclusive, transformative and build-for-purpose diagnostics and therapeutics to the huge, unmet genetic healthcare market. Our current pipeline covers early cancer detection, treatment selection, monitoring recurrence to therapeutics.
PGA (patient-derived gene expression-informed anti-cancer drug efficacy) is the flagship assay which can provide comprehensive anti-cancer drug efficacy data within 5 days and improve the clinical-benefit rate for cancer patients. PGA’s unprecedented potential of selecting the optimal regimen among hundreds of anti-cancer drugs for individual patients based on their own gene expression signatures is truly a breakthrough.
For cancer early detection, OncoDxRx scientists have identified 10 CpG methylation biomarkers with AUC of 0.895 for 14 cancer types.
One-of-a-kind assays for MRD, DNA repair activity (HRR and/or MMR), tissue-of-origin as well as cancer drug discovery are also progressing as planned.
OncoDxRx is seeking for investors/buyers/partners to further our mission.
Company Details
- Founded
- -
- Address
- 150 N Santa Anita Ave, Los Angeles,california 91006,united States
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Keywords
- OneDX.
- HQ
- Los Angeles, California
Oncodxrx Questions
Oncodxrx's LinkedIn profile is https://www.linkedin.com/company/oncodxrx
Oncodxrx's industry is
Medical and Diagnostic Laboratories
Oncodxrx's top competitors are
Crollusions Marketing Agency,
Clarity Biologics,
Onedx,
Maravai Lifesciences,
Medrxiv,
Abbvie,
Saniva Diagnostics Gmbh,
Circulogene,
Growth River,
Epm Group Consulting.
Oncodxrx's categories are Medical and Diagnostic Laboratories
Oncodxrx's founding year is 2021
